News
07 October 2026
A Strong Start for INSIGHT 2026 in Dublin
Scientists, industry experts, and innovators gathered in Dublin for the opening day of INSIGHT 2026, exploring key advances in dissolution science, predictive development, release testing, and complex dosage forms.
Day 1 of INSIGHT 2026 brought together pharmaceutical scientists, industry experts, and thought leaders from around the world to discuss the innovations and scientific developments shaping the future of pharmaceutical testing.
The conference opened with a series of presentations addressing some of today's most important challenges in analytical development and quality testing. Topics included advanced dissolution science, the integration of in vitro testing into PBPK models, dissolution method development, and innovative release testing approaches for parenteral products. Throughout the day, speakers provided valuable perspectives on how scientific advances are helping laboratories better understand complex drug products and improve decision-making across development and quality control.
In addition to the scientific sessions, participants engaged in interactive workshops exploring modern dissolution strategies for complex dosage forms. Combining scientific exchange with practical application, the sessions provided valuable insights that attendees can take back to their own laboratories.
Beyond the program itself, the first day was characterized by lively discussions, knowledge exchange, and new connections between experts from academia and industry. Bringing together diverse perspectives remains a central objective of INSIGHT 2026 and was evident throughout the opening day.
With another full day of presentations, workshops, and discussions ahead, the conversation continues tomorrow in Dublin.